{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:05:23Z","timestamp":1790643923762,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cardiomyocyte hypertrophy is a major outcome of pathological cardiac hypertrophy. The m6A demethylase ALKBH5 is reported to be associated with cardiovascular diseases, whereas the functional role of ALKBH5 in cardiomyocyte hypertrophy remains confused. We engineered <jats:italic>Alkbh5<\/jats:italic> siRNA (si<jats:italic>Alkbh5<\/jats:italic>) and <jats:italic>Alkbh5<\/jats:italic> overexpressing plasmid (<jats:italic>Alkbh5<\/jats:italic> OE) to transfect cardiomyocytes. Subsequently, RNA immunoprecipitation (RIP)-qPCR, MeRIP-qPCR analysis and the dual-luciferase reporter assays were applied to elucidate the regulatory mechanism of ALKBH5 on cardiomyocyte hypertrophy. Our study identified ALKBH5 as a new contributor of cardiomyocyte hypertrophy. ALKBH5 showed upregulation in both phenylephrine (PE)-induced cardiomyocyte hypertrophic responses in vitro and transverse aortic constriction (TAC)\/high fat diet (HFD)-induced pathological cardiac hypertrophy in vivo. Knockdown or overexpression of ALKBH5 regulated the occurrence of hypertrophic responses, including the increased cardiomyocyte surface areas and elevation of the hypertrophic marker levels, such as brain natriuretic peptide (BNP) and atrial natriuretic peptide (ANP). Mechanically, we indicated that ALKBH5 activated JAK2\/STAT3 signaling pathway and mediated m6A demethylation on <jats:italic>Stat3<\/jats:italic> mRNA, but not <jats:italic>Jak2<\/jats:italic> mRNA, resulting in the phosphorylation and nuclear translocation of STAT3, which enhances the transcription of hypertrophic genes (e.g., <jats:italic>Nppa<\/jats:italic>) and ultimately leads to the emergence of cardiomyocytes hypertrophic growth. Our work highlights the functional role of ALKBH5 in regulating the onset of cardiomyocyte hypertrophy and provides a potential target for hypertrophic heart diseases prevention and treatment.<\/jats:p>","DOI":"10.1038\/s41419-024-07053-2","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:55:51Z","timestamp":1726786551000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The functional role of m6A demethylase ALKBH5 in cardiomyocyte hypertrophy"],"prefix":"10.1038","volume":"15","author":[{"given":"Chen","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiling","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghua","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4768-2286","authenticated-orcid":false,"given":"Di","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"7053_CR1","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1161\/CIRCULATIONAHA.116.023518","volume":"133","author":"JE Udelson","year":"2016","unstructured":"Udelson JE, Stevenson LW. The future of heart failure diagnosis, therapy, and management. Circulation. 2016;133:2671\u201386.","journal-title":"Circulation"},{"key":"7053_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s43657-021-00037-8","volume":"2","author":"M Picard","year":"2022","unstructured":"Picard M. Why do we care more about disease than health? Phenomics. 2022;2:145\u201355.","journal-title":"Phenomics"},{"key":"7053_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s43657-021-00022-1","volume":"1","author":"H Zhang","year":"2021","unstructured":"Zhang H, Hua X, Song J. Phenotypes of cardiovascular diseases: current status and future perspectives. Phenomics. 2021;1:229\u201341.","journal-title":"Phenomics"},{"key":"7053_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"7053_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00018-023-04805-9","volume":"80","author":"H Su","year":"2023","unstructured":"Su H, Xu J, Su Z, Xiao C, Wang J, Zhong W, et al. Poly (ADP-ribose) polymerases 16 triggers pathological cardiac hypertrophy via activating IRE1alpha-sXBP1-GATA4 pathway. Cell Mol Life Sci. 2023;80:161.","journal-title":"Cell Mol Life Sci"},{"key":"7053_CR6","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1161\/CIRCULATIONAHA.117.031659","volume":"137","author":"KQ Deng","year":"2018","unstructured":"Deng KQ, Zhao GN, Wang Z, Fang J, Jiang Z, Gong J, et al. Targeting transmembrane BAX inhibitor motif containing 1 alleviates pathological cardiac hypertrophy. Circulation. 2018;137:1486\u2013504.","journal-title":"Circulation"},{"key":"7053_CR7","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/bph.13861","volume":"175","author":"G Meng","year":"2018","unstructured":"Meng G, Liu J, Liu S, Song Q, Liu L, Xie L, et al. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. Br J Pharm. 2018;175:1126\u201345.","journal-title":"Br J Pharm"},{"key":"7053_CR8","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1093\/cvr\/cvx030","volume":"113","author":"K Stellos","year":"2017","unstructured":"Stellos K. The rise of epitranscriptomic era: implications for cardiovascular disease. Cardiovasc Res. 2017;113:e2\u2013e3.","journal-title":"Cardiovasc Res"},{"key":"7053_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.stem.2014.09.019","volume":"15","author":"PJ Batista","year":"2014","unstructured":"Batista PJ, Molinie B, Wang J, Qu K, Zhang J, Li L, et al. mA RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15:707\u201319.","journal-title":"Cell Stem Cell"},{"key":"7053_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s43657-021-00043-w","volume":"3","author":"J Zhao","year":"2023","unstructured":"Zhao J, Xu H, Su Y, Pan J, Xie S, Xu J, et al. Emerging regulatory mechanisms of N(6)-Methyladenosine modification in cancer metastasis. Phenomics. 2023;3:83\u2013100.","journal-title":"Phenomics"},{"key":"7053_CR11","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, Lin K, Zheng S, Lu Z, et al. m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell. 2017;31:591\u2013606 e596.","journal-title":"Cancer Cell"},{"key":"7053_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s12253-019-00737-7","volume":"26","author":"P Yang","year":"2020","unstructured":"Yang P, Wang Q, Liu A, Zhu J, Feng J. ALKBH5 holds prognostic values and inhibits the metastasis of colon cancer. Pathol Oncol Res. 2020;26:1615\u201323.","journal-title":"Pathol Oncol Res"},{"key":"7053_CR13","doi-asserted-by":"crossref","unstructured":"Xu K, Mo Y, Li D, Yu Q, Wang L, Lin F, et al. N(6)-methyladenosine demethylases Alkbh5\/Fto regulate cerebral ischemia-reperfusion injury. Ther Adv Chronic Dis. 2020;11:2040622320916024.","DOI":"10.1177\/2040622320916024"},{"key":"7053_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.402","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Hu J, Sun X, Yang K, Yang L, Kong L, et al. Loss of m6A demethylase ALKBH5 promotes post-ischemic angiogenesis via post-transcriptional stabilization of WNT5A. Clin Transl Med. 2021;11:e402.","journal-title":"Clin Transl Med"},{"key":"7053_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41401-021-00828-9","volume":"43","author":"S Zhao","year":"2021","unstructured":"Zhao S, Song TY, Wang ZY, Gao J, Cao JW, Hu LL. et al. S-nitrosylation of Hsp90 promotes cardiac hypertrophy in mice through GSK3beta signaling. Acta Pharmacol Sin. 2021;43:1979\u201388.","journal-title":"Acta Pharmacol Sin"},{"key":"7053_CR16","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1080\/15548627.2019.1586246","volume":"15","author":"H Song","year":"2019","unstructured":"Song H, Feng X, Zhang H, Luo Y, Huang J, Lin M, et al. METTL3 and ALKBH5 oppositely regulate m(6)A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes. Autophagy. 2019;15:1419\u201337.","journal-title":"Autophagy"},{"key":"7053_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.115.017472","volume":"133","author":"W Zhang","year":"2016","unstructured":"Zhang W, Qu X, Chen B, Snyder M, Wang M, Li B, et al. Critical roles of STAT3 in beta-adrenergic functions in the heart. Circulation. 2016;133:48\u201361.","journal-title":"Circulation"},{"key":"7053_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.vph.2006.05.006","volume":"45","author":"DL Beckles","year":"2006","unstructured":"Beckles DL, Mascareno E, Siddiqui MA. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy. Vasc Pharm. 2006;45:350\u20137.","journal-title":"Vasc Pharm"},{"key":"7053_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1073\/pnas.97.1.315","volume":"97","author":"K Kunisada","year":"2000","unstructured":"Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA. 2000;97:315\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7053_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13046-021-02088-1","volume":"40","author":"S Nie","year":"2021","unstructured":"Nie S, Zhang L, Liu J, Wan Y, Jiang Y, Yang J, et al. ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Exp Clin Cancer Res. 2021;40:284.","journal-title":"J Exp Clin Cancer Res"},{"key":"7053_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145:829\u201346.","journal-title":"Circulation"},{"key":"7053_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06639-7","volume":"9","author":"S Nomura","year":"2018","unstructured":"Nomura S, Satoh M, Fujita T, Higo T, Sumida T, Ko T, et al. Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure. Nat Commun. 2018;9:4435.","journal-title":"Nat Commun"},{"key":"7053_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/iub.2163","volume":"72","author":"J Whitcomb","year":"2020","unstructured":"Whitcomb J, Gharibeh L, Nemer M. From embryogenesis to adulthood: critical role for GATA factors in heart development and function. IUBMB Life. 2020;72:53\u201367.","journal-title":"IUBMB Life"},{"key":"7053_CR24","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/s41556-020-0576-y","volume":"22","author":"XQ Gao","year":"2020","unstructured":"Gao XQ, Zhang YH, Liu F, Ponnusamy M, Zhao XM, Zhou LY, et al. The piRNA CHAPIR regulates cardiac hypertrophy by controlling METTL3-dependent N(6)-methyladenosine methylation of Parp10 mRNA. Nat Cell Biol. 2020;22:1319\u201331.","journal-title":"Nat Cell Biol"},{"key":"7053_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbrc.2009.07.147","volume":"388","author":"JP Munoz","year":"2009","unstructured":"Munoz JP, Collao A, Chiong M, Maldonado C, Adasme T, Carrasco L, et al. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. Biochem Biophys Res Commun. 2009;388:155\u201360.","journal-title":"Biochem Biophys Res Commun"},{"key":"7053_CR26","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/CIRCRESAHA.119.315861","volume":"126","author":"S Ye","year":"2020","unstructured":"Ye S, Luo W, Khan ZA, Wu G, Xuan L, Shan P, et al. Celastrol attenuates angiotensin II-induced cardiac remodeling by targeting STAT3. Circ Res. 2020;126:1007\u201323.","journal-title":"Circ Res"},{"key":"7053_CR27","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.chembiol.2006.09.018","volume":"13","author":"J Schust","year":"2006","unstructured":"Schust J, Sperl B, Hollis A, Mayer TU, Berg T. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol. 2006;13:1235\u201342.","journal-title":"Chem Biol"},{"key":"7053_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","volume":"65","author":"N Frey","year":"2003","unstructured":"Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 2003;65:45\u201379.","journal-title":"Annu Rev Physiol"},{"key":"7053_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","volume":"47","author":"SJ Watkins","year":"2011","unstructured":"Watkins SJ, Borthwick GM, Arthur HM. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. Vitr Cell Dev Biol Anim. 2011;47:125\u201331.","journal-title":"Vitr Cell Dev Biol Anim"},{"key":"7053_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00018-016-2373-0","volume":"74","author":"ZK Haque","year":"2017","unstructured":"Haque ZK, Wang DZ. How cardiomyocytes sense pathophysiological stresses for cardiac remodeling. Cell Mol Life Sci. 2017;74:983\u20131000.","journal-title":"Cell Mol Life Sci"},{"key":"7053_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10741-007-9007-4","volume":"12","author":"OE Osadchii","year":"2007","unstructured":"Osadchii OE. Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. Heart Fail Rev. 2007;12:66\u201386.","journal-title":"Heart Fail Rev"},{"key":"7053_CR32","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/j.1440-1681.2004.04063.x","volume":"31","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Yan J, Chen K, Song Y, Lu Z, Chen M, et al. Different roles of alpha1-adrenoceptor subtypes in mediating cardiomyocyte protein synthesis in neonatal rats. Clin Exp Pharm Physiol. 2004;31:626\u201333.","journal-title":"Clin Exp Pharm Physiol"},{"key":"7053_CR33","doi-asserted-by":"publisher","first-page":"26227","DOI":"10.1016\/S0021-9258(18)47183-9","volume":"269","author":"DS Hanford","year":"1994","unstructured":"Hanford DS, Thuerauf DJ, Murray SF, Glembotski CC. Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem. 1994;269:26227\u201333.","journal-title":"J Biol Chem"},{"key":"7053_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.trsl.2016.03.002","volume":"172","author":"J Lu","year":"2016","unstructured":"Lu J, Sun D, Liu Z, Li M, Hong H, Liu C, et al. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy. Transl Res. 2016;172:96\u2013112 e116.","journal-title":"Transl Res"},{"key":"7053_CR35","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-X","volume":"98","author":"BW Kimes","year":"1976","unstructured":"Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res. 1976;98:367\u201381.","journal-title":"Exp Cell Res"},{"key":"7053_CR36","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/01.RES.69.6.1476","volume":"69","author":"J Hescheler","year":"1991","unstructured":"Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res. 1991;69:1476\u201386.","journal-title":"Circ Res"},{"key":"7053_CR37","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1080\/21655979.2022.2031388","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Chen Y, Chen H, Shen Y, Pang L, Wu W, et al. Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3. Bioengineered. 2022;13:4260\u201370.","journal-title":"Bioengineered"},{"key":"7053_CR38","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1038\/s41418-021-00789-w","volume":"28","author":"J Lu","year":"2021","unstructured":"Lu J, Xu S, Huo Y, Sun D, Hu Y, Wang J, et al. Sorting nexin 3 induces heart failure via promoting retromer-dependent nuclear trafficking of STAT3. Cell Death Differ. 2021;28:2871\u201387.","journal-title":"Cell Death Differ"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07053-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:55:56Z","timestamp":1726786556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-024-07053-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["7053"],"URL":"https:\/\/doi.org\/10.1038\/s41419-024-07053-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the animal experimental procedures were conformed to the Animal Welfare Act Guide for Use and Care of Laboratory Animals, and an Institutional Animal Care and Use Committee (IACUC)-approved protocol of Fudan University, China. Mice were housed under specific pathogen-free (SPF) conditions at a stable temperature of 24\u2009\u00b0C and fed with chow diet and water at libitum. The male mice were chosen due to the variables (uncertain hormone changes et al.) in female mice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the content of this manuscript and agreed to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"683"}}